Document Type: Original Research Article

Authors

Department of Para- Clinical Sciences, Pathology and Microbiology Unit, Faculty of Medical Sciences, University of the West Indies, Eric Williams Medical Complex, Mt. Hope Hospital, Champs Fleurs, Trinidad and Tobago, West Indies.

Abstract

Background:
Serratia marcescens is a gram-negative bacterium from family of Enterobacteriaceae. It is a human pathogen that is involved in nosocomial infection outbreaks that have proven difficult to manage. PCR-based techniques are suitable given the genus. Serratia has a higher GC content than many other members of the Enterobacteriaceae. The ERIC PCR-based fingerprinting method was used to study the PCR patterns of clinical Serratia marcescens isolates and antimicrobial susceptibility profiles.
Methods: Surveillance was conducted for nosocomial cases of interest and the nosocomial pathogens were retrieved for identification via morphological and additional biochemical tests. Additionally, antimicrobial susceptibility tests and ERIC Polymerase Chain Reaction (PCR) based fingerprinting molecular method was done on the clinical S. marcescens isolates.
Results: From the study, five different strains of the clinical Serratia marcescens isolates were recovered and similarly five distinct susceptibility patterns were observed from the clinical S. marcescens isolates indicating consistency in the number of strains present in the clinical S. marcescens isolates.
Conclusions: ERIC PCR fingerprinting base technique; a simple, rapid and cheap method for the determination of genetic relatedness between Serratia marcescens isolates can be applied for the thorough evaluation of nosocomial outbreaks to detect the source of infection and control the spreading of the infection.

Graphical Abstract

Keywords

Main Subjects

REFERENCES

 

 

[1]    V. Adamson, P. Mitt, H. Pisarev, T. Metsvaht, K. Telling, P. Naaber, M. Maimets, Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case–control study, BMC Infect. Dis. 12 (2012) 281.

[2]    R. Hertle, H. Schwarz, Serratia marcescens internalization and replication in human bladder epithelial cells, BMC Infect. Dis. 4 (2004) 16.

[3]    B.E. Ostrowsky, C. Whitener, H.K. Bredenberg, L.A. Carson, S. Holt, L. Hutwagner, M.J. Arduino, W.R. Jarvis, Serratia marcescens bacteremia traced to an infused narcotic, N. Engl. J. Med. 346 (2002) 1529–1537.

[4]    C. Montagnani, P. Cocchi, L. Lega, S. Campana, K.P. Biermann, C. Braggion, P. Pecile, E. Chiappini, M. De Martino, L. Galli, Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants, BMC Infect. Dis. 15 (2015) 11.

[5]    A. babaei, A. Taheri, Direct Electrochemistry and Electrocatalysis of Myoglobin Immobilized on a Novel Chitosan-Nickel Hydroxide Nanoparticles-Carbon Nanotubes Biocomposite Modified Glassy Carbon Electrode, Anal Bioanal Electrochem, 4(2012) 342 - 56.

[6]    A. Voelz, A. Müller, J. Gillen, C. Le, T. Dresbach, S. Engelhart, M. Exner, C.J. Bates, A. Simon, Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: clinical aspects, risk factors and management, Int. J. Hyg. Environ. Health. 213 (2010) 79–87.

[7]    V. Rabier, S. Bataillon, A. Jolivet‐Gougeon, J. Chapplain, A. Beuchée, P. Bétrémieux, Hand washing soap as a source of neonatal Serratia marcescens outbreak, Acta Paediatr. 97 (2008) 1381–1385.

[8]    S. Buffet-Bataillon, V. Rabier, P. Bétrémieux, A. Beuchée, M. Bauer, P. Pladys, E. Le Gall, M. Cormier, A. Jolivet-Gougeon, Outbreak of Serratia marcescens in a neonatal intensive care unit: contaminated unmedicated liquid soap and risk factors, J. Hosp. Infect. 72 (2009) 17–22.

[9]    P. Villari, M. Crispino, A. Salvadori, A. Scarcella, Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit, Infect. Control Hosp. Epidemiol. 22 (2001) 630–634.

[10]  S. Gaisser, V. Braun, The tonB gene of Serratia marcescens: sequence, activity and partial complementation of Escherichia coli tonB mutants, Mol. Microbiol. 5 (1991) 2777–2787.

[11]  S.B. Debast, W.J.G. Melchers, A. Voss, J.A.A. Hoogkamp-Korstanje, J. Meis, Epidemiological survey of an outbreak of multiresistantSerratia marcescens by PCR-fingerprinting, Infection. 23 (1995) 267–271.

[12]  J. Welsh, M. McClelland, Fingerprinting genomes using PCR with arbitrary primers, Nucleic Acids Res. 18 (1990) 7213–7218.

[13]  P.Y. Liu, Y.-J. Lau, B. Hu, J.-M. Shir, M.-H. Cheung, Z.-Y. Shi, W.-S. Tsai, Use of PCR to study epidemiology of Serratia marcescens isolates in nosocomial infection., J. Clin. Microbiol. 32 (1994) 1935–1938.

[14]  T.G. Patton, S. Katz, R.J. Sobieski, S.S. Crupper, Genotyping of clinical Serratia marcescens isolates: a comparison of PCR-based methods, FEMS Microbiol. Lett. 194 (2001) 19–25.

[15]  R.G.C. Carvalho, I.C. do R.S. Carneiro, M.S. Pinheiro, S. da C. Pinheiro, P.S.R. Azevedo, S.D. dos Santos, A.R.F. da Costa, F.L. de P. Ramos, K.V.B. Lima, Caracterização fenotípica e genotípica de Serratia marcescens provenientes de Unidade Neonatal de Referência em Belém, Pará, Brasil, Rev. Pan-Amazônica Saúde. 1 (2010) 101–106.

[16]  P.A. Parment, The role of Serratia marcescens in soft contact lens associated ocular infections: a review, Acta Ophthalmol. Scand. 75 (1997) 67–71.

[17]  R. Hertle, Serratia type pore forming toxins, Curr. Protein Pept. Sci. 1 (2000) 75–89.

[18]  R. Hertle, The family of Serratia type pore forming toxins, Curr. Protein Pept. Sci. 6 (2005) 313–325.

[19]  U. Arslan, I. Erayman, S. Kirdar, S. Yuksekkaya, O. Cimen, I. Tuncer, B. Bozdogan, Serratia marcescens sepsis outbreak in a neonatal intensive care unit, Pediatr. Int. 52 (2010) 208–212.

[20]  Z.-Y. Shi, P.Y. Liu, Y.-J. Lau, Y.-H. Lin, B.-S. Hu, Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens., J. Clin. Microbiol. 35 (1997) 325–327.

[21]  S. Ktari, F. Mahjoubi, B. Mnif, H. Kallel, M. Bouaziz, A. Hammami, Investigation of three nosocomial outbreaks of Serratia marcescens in an intensive care unit in Sfax-Tunisia, Tunis. Med. 88 (2010) 501–506.

[22]  m. Afrasiabi, Z. Rezayati-zad, s. Kianipour, A. babaei, A. Taheri, A Sensor for Determination of Tramadol in Pharmaceutical Preparations and Biological Fluids Based on Multi-Walled Carbon Nanotubes-Modified Glassy Carbon Electrode, JChemSocpak, 35(2013) 1106-12.

[23]  C. Sartor, V. Jacomo, C. Duvivier, H. Tissot-Dupont, R. Sambuc, M. Drancourt, Nosocomial Serratia marcescens infections associated with extrinsic contamination of a liquid nonmedicated soap, Infect. Control Hosp. Epidemiol. 21 (2000) 196–199.

[24]  G. Bayramoglu, K. Buruk, U. Dinc, M. Mutlu, G. Yilmaz, Y. Aslan, Investigation of an outbreak of Serratia marcescens in a neonatal intensive care unit, J. Microbiol. Immunol. Infect. 44 (2011) 111–115.

[25]  V. Milisavljevic, F. Wu, E. Larson, D. Rubenstein, B. Ross, L.M. Drusin, P. Della-Latta, L. Saiman, Molecular epidemiology of Serratia marcescens outbreaks in two neonatal intensive care units, Infect. Control Hosp. Epidemiol. 25 (2004) 719–722.

[26]  V. Crivaro, M. Bagattini, M.F. Salza, F. Raimondi, F. Rossano, M. Triassi, R. Zarrilli, Risk factors for extended-spectrum β-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit, J. Hosp. Infect. 67 (2007) 135–141.

 

 

 

 

 

 

HOW TO CITE THIS ARTICLE

C. Elliott, A.l Justiz Vaillant, Antimicrobials and Enterobacterial Repetitive Intergenic Consensus (ERIC) Polymerase Chain Reaction (PCR) patterns of nosocomial Serratia marcescens isolates: A One Year Prospective Study (June 2013-May 2014) in a Rural Hospital in the Republic of Trinidad and Tobago,  Prog. Chem. Biochem. Res. 2020, 3(2), 114-120.

DOI: 10.33945/SAMI/PCBR.2020.2.4
URL: http://www.pcbiochemres.com/article_106600.html